These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 199544)

  • 1. Cell mediated immunity during infectious mononucleosis to Epstein-Barr virus associated antigens.
    Periman P; Levine PH; Ablashi DV; Royston I
    Int J Cancer; 1977 Oct; 20(4):506-11. PubMed ID: 199544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of cell-mediated immunity to Epstein-Barr herpesvirus in infectious mononucleosis as shown by leukocyte migration inhibition.
    Lai PK; Alpers MP; MacKay-Scollay EM
    Infect Immun; 1977 Jul; 17(1):28-35. PubMed ID: 195902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte responses to EBV-associated antigens in infectious mononucleosis, and Hodgkin's and non-Hodgkin's lymphoma patients, with the leukocyte adherence inhibition assay.
    Chan SH; Wallen WC; Levine PH; Periman P; Perlin E
    Int J Cancer; 1977 Mar; 19(3):356-63. PubMed ID: 191408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses.
    Szigeti R; Rabin H; Timar L; Klein G
    Intervirology; 1986; 26(3):121-8. PubMed ID: 3034820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity to Epstein-Barr virus and a blocking factor in patients with infectious mononucleosis.
    Lai PK; Mackay-Scollay EM; Fimmel PJ; Alpers MP; Keast D
    Nature; 1974 Dec; 252(5484):608-10. PubMed ID: 4372559
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters.
    Nikoskelainen J; Ablashi DV; Isenberg RA; Neel EU; Miller RG; Stevens DA
    J Immunol; 1978 Oct; 121(4):1239-44. PubMed ID: 81224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells.
    Szigeti R; Timar L; Weiland O; Henle W; Henle G; Hennessy K; Kieff E; Sulitzeanu D; Dillner J; Klein G
    Clin Immunol Immunopathol; 1986 Dec; 41(3):342-50. PubMed ID: 3022972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study on infectious mononucleosis in childhood--symptoms, serology, Epstein-Barr-Virus specific leukocyte migration inhibition.
    Timár L; Budai J; Koller M
    Infection; 1982; 10(3):139-43. PubMed ID: 6286500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte reactivity in infectious mononucleosis.
    ten Napel CH; The TH
    J Infect Dis; 1980 Jun; 141(6):716-23. PubMed ID: 6248602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte migration inhibition with Epstein-Barr virus negative and positive cell extracts.
    Szigeti R; Timár L; Révész T
    Allergy; 1980 Mar; 35(2):97-103. PubMed ID: 6155797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation.
    Lewin N; Aman P; Akerlund B; Gustavsson E; Carenfelt C; Lejdeborn L; Klein G; Klein E
    Immunol Lett; 1990 Oct; 26(1):59-65. PubMed ID: 2177451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of migration inhibitory factor (MIF) by human leukocytes following exposure to Epstein-Barr virus.
    Wilson GL; Young BG
    Cell Immunol; 1978 Jun; 38(1):147-56. PubMed ID: 208782
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of different Epstein-Barr virus-determined antigens (EBNA, EA, and VCA) on the leukocyte migration of healthy donors and patients with infectious mononucleosis and certain immunodeficiencies.
    Szigeti R; Masucci MG; Henle W; Henle G; Purtilo D; Klein G
    Clin Immunol Immunopathol; 1982 Jan; 22(1):128-38. PubMed ID: 6288294
    [No Abstract]   [Full Text] [Related]  

  • 14. Abrogation of cell-mediated immunity by a serum blocking factor isolated from patients with infectious mononucleosis.
    Wainwright WH; Veltri RW; Sprinkle PM
    J Infect Dis; 1979 Jul; 140(1):22-32. PubMed ID: 88489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of in vitro immune responses to Epstein-Barr herpesvirus and severity of infectious mononucleosis.
    Goldstein K; Lai PK; Lightfoote M; Andrese AP; Fuccillo D; Connor RJ; Levine PH
    Infect Immun; 1980 Sep; 29(3):945-52. PubMed ID: 6253402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
    Royston I; Sullivan JL; Periman PO; Perlin E
    N Engl J Med; 1975 Dec; 293(23):1159-63. PubMed ID: 171568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression].
    Szigeti R; Klein E; Masucci MG; Ernberg I; Masucci G; Svedmyr E; Klein G
    Orv Hetil; 1982 May; 123(20):1217-21. PubMed ID: 6287380
    [No Abstract]   [Full Text] [Related]  

  • 18. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M; Myc A; Matej H; Rudzka L
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series.
    Fark AR
    J Fam Pract; 1991 Feb; 32(2):202, 205-6, 209. PubMed ID: 1846641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
    Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.